Chamonix Michaud

Biomedical engineering

Hometown: Green Bay, Wisconsin, United States

Graduation date: Spring 2022

Michaud Chamonix
Health icon, disabled. A red heart with a cardiac rhythm running through it.

FURI | Fall 2021

Development of CRISPR Interference Constructs to Modulate the Phenotypic Switch of Vascular Smooth Muscle Cells

Previous studies highlight the critical role that upregulation of Kruppel-like factor 4 (KLF4) plays in promoting the pathological phenotype of vascular smooth muscle cells (VSMCs). This FURI project adopted a CRISPR Interference (CRISPRi) approach to perturb KLF4 expression and exert an anti-proliferative effect on cultured VSMCs. Specifically, small guide RNAs (sgRNA) targeting the KLF4 gene locus were subcloned to a viral vector carrying a nuclease dead Cas9 fused with a transcriptional repressor. The research team is producing recombinant viral vectors (rAAV) and will further determine the extent to which the CRISPRi constructs suppress KLF4 expression and the pathological phenotype of VSMCs.



QR code for the current page

It’s hip to be square.

Students presenting projects at the Fulton Forge Student Research Expo are encouraged to download this personal QR code and include it within your poster. This allows expo attendees to explore more about your project and about you in the future. 

Right click the image to save it to your computer.

Additional projects from this student

Developing a genome engineering approach to fine-tune the transcriptional regulation in vascular smooth muscle cells will help people with vascular stenosis.


  • FURI
  • Summer 2021